Table 2. Cox regression model.
| n | Multivariate**** | ||||||
|---|---|---|---|---|---|---|---|
| Univariate | with T, N and T/N | ||||||
| HR | 95% CI | p | HR | 95% CI | p | ||
| ESRP1_T | |||||||
| <66.67 | 25 | ref | ref | ||||
| >=66.67 | 43 | 0.30 | 0.12 - 0.74 | 0.009 | 0.36 | 0.15 - 0.91 | 0.032 |
| ESRP1_N | |||||||
| <66.67 | 17 | ref | ref | ||||
| >=66.67 | 51 | 0.56 | 0.22 - 1.41 | 0.217 | 0.38 | 0.12 - 1.15 | 0.087 |
| ESRP1_T/N | |||||||
| <0.269 | 22 | ref | ref | ||||
| >=0.269 | 45 | 0.47 | 0.19 - 1.14 | 0.094 | 0.43 | 0.15 - 1.22 | 0.113 |
| ESRP2_T | |||||||
| <131.1 | 29 | ref | ref | ||||
| >=131.1 | 39 | 0.26 | 0.10 - 0.69 | 0.006 | 0.23 | 0.08 - 0.65 | 0.006 |
| ESRP2_N | |||||||
| <131.1 | 18 | ref | ref | ||||
| >=131.1 | 50 | 0.62 | 0.25 - 1.55 | 0.304 | 0.56 | 0.18 - 1.72 | 0.309 |
| ESRP2_T/N | |||||||
| <0.668 | 41 | ref | ref | ||||
| >=0.668 | 26 | 2.11 | 0.87 - 5.09 | 0.097 | 2.10 | 0.76-5.80 | 0.153 |
| Instability | |||||||
| Instable | 11 | ref | |||||
| stable | 57 | 1.04 | 0.30 - 3.54 | 0.954 | |||
| Gender | |||||||
| f | 26 | ref | |||||
| m | 42 | 1.29 | 0.51 −3.23 | 0.589 | |||
| Tumor site | |||||||
| rectum | 13 | ref | |||||
| colon | 55 | 0.67 | 0.24-1.85 | 0.443 | |||
| Grade | |||||||
| 2 | 45 | ref | |||||
| 3 | 22 | 1.21 | 0.48 - 3.04 | 0.685 | |||
| Stage | |||||||
| I | 11 | ref | |||||
| II | 28 | 0.85 | 0.22 - 3.29 | 0.815 | |||
| III-IV | 29 | 1.39 | 0.38 - 5.00 | 0.629 | |||
| p-trend | 1.28 | 0.67 - 2.44 | 0.455 | ||||
| Age | 1.05 | 1.00 - 1.10 | 0.068 | ||||
adjusted with age, stage, grade, tumor site, gender, microsatellite stability for each gene expression in each type of tissue in bold are marked p values <0.1.